KMRC011, an agonist of toll-like receptor 5, mitigates irradiation-induced tissue damage and mortality in cynomolgus monkeys
In the study here, the potential applicability of KMRC011 - an agonist of toll-like receptor-5 – as a countermeasure for radiation toxicities was evaluated. Following a single 5.5 Gy total body irradiation (TBI, surface absorbed dose = 7 Gy) of Co60 γ-rays, mortality rates and degrees of pathologica...
Main Authors: | Hong-Soo Lee, Doo-Wan Cho, Ji-Seok Han, Su-Cheol Han, Sang Keun Woo, Soo-Youn Jun, Woo-Jong Lee, Susie Yoon, Son-Il Pak, Sang-Jin Lee, Eunsol Seong, Eun-Jung Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Journal of Immunotoxicology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/1547691X.2019.1699617 |
Similar Items
-
Clinical evaluation of toll-like receptor-5 agonist for radiation-induced oral mucositis in beagle dogs
by: Jaeeun Ko, et al.
Published: (2022-08-01) -
A first‐in‐human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics
by: Eunsol Yang, et al.
Published: (2021-11-01) -
Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models
by: Bingyu Ye, et al.
Published: (2018-06-01) -
Internal contamination cases: The REAC/TS experience
by: Jason Davis, et al.
Published: (2022-07-01) -
Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
by: Sarita Garg, et al.
Published: (2022-04-01)